Digest Network Come funziona
Network
/
Società
Si
Non verificato

Sinovac Biotech Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniMedicina - VarieSalute

23 comunicati stampa

Guarda tutti i comunicati
15/07/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Titoli e azioni
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
15/06/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
05/06/2026
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Mercato azionario
Titoli e azioni
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
29/05/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
21/05/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Titoli e azioni
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
30/04/2026
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
22/01/2026
Biotecnologia
Farmaceutica
Salute
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
04/01/2026
Mercato del lavoro
Legge/Diritto
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
04/01/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
17/12/2025
Biotecnologia
Farmaceutica
Salute
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0